A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer.
BACKGROUND: We performed a pilot study, looking at the COX-2 inhibitor celecoxib, on newly diagnosed prostate cancer patients in the neo-adjuvant setting using DNA microarray analysis. PATIENTS AND METHODS: This was a single-blinded, randomized controlled phase II presurgical (radical prostatectomy...
Glavni autori: | Sooriakumaran, P, Macanas-Pirard, P, Bucca, G, Henderson, A, Langley, SE, Laing, R, Smith, C, Laing, E, Coley, H |
---|---|
Format: | Journal article |
Jezik: | English |
Izdano: |
2009
|
Slični predmeti
-
A blinded, randomized controlled trial of neo-adjuvant celecoxib in patients with early prostate cancer.
od: Sooriakumaran, P, i dr.
Izdano: (2006) -
A randomized controlled trial investigating the effects of celecoxib in patients with localized prostate cancer.
od: Sooriakumaran, P, i dr.
Izdano: (2009) -
A blinded, randomised controlled trial of neo-adjuvant Celecoxib in patients with localised prostate cancer
od: Sooriakumaran, P, i dr.
Izdano: (2007) -
COX-2 inhibition: a possible role in the management of prostate cancer?
od: Sooriakumaran, P, i dr.
Izdano: (2007) -
A novel method of obtaining prostate tissue for gene expression profiling.
od: Sooriakumaran, P, i dr.
Izdano: (2009)